Named originally for their effects on peripheral end organs, the melanocortin system controls a diverse set of physiological processes through a series of five G-protein-coupled receptors and several sets of small peptide ligands. The central melanocortin system plays an essential role in homeostatic regulation of body weight, in which two alternative ligands, a-melanocytestimulating hormone and agouti-related protein, stimulate and inhibit receptor signaling in several key brain regions that ultimately affect food intake and energy expenditure. Much of what we know about the relationship between central melanocortin signaling and body weight regulation stems from genetic studies. Comparative genomic studies indicate that melanocortin receptors used for controlling pigmentation and body weight regulation existed more than 500 million years ago in primitive vertebrates, but that fine-grained control of melanocortin receptors through neuropeptides and endogenous antagonists developed more recently. Recent studies based on dog coat-color genetics revealed a new class of melanocortin ligands, the b-defensins, which reveal the potential for cross talk between the melanocortin and the immune systems.
Introduction
The last decade has been a period of remarkable progress for the neuroendocrinology of body weight regulation, fueled by advances in genetics and genomics. Availability of fully sequenced genomes from an increasing number of mammals has revealed hundreds of genes that encode previously unidentified putative hormones, receptors, and downstream signaling components; advances in embryonic stem cell and gene targeting technology have also enabled the physiological function of those genes to be tested in a sophisticated and rigorous manner in laboratory mice; and new approaches for high-throughput DNA sequencing have allowed homologous genotype-phenotype correlations to be made in human biology and disease. [1] [2] [3] [4] Together, these efforts have led to a new depth of understanding with regard as to how the central nervous system regulates essential physiological functions in the rest of the body. [5] [6] [7] These ideas are exemplified by the agouti-melanocortin pathway, a series of five G-protein-coupled receptors and an increasing number of paracrine ligands expressed in the complex sets of mammalian cells, which help regulate diverse aspects of normal and abnormal physiology. [8] [9] [10] [11] [12] Although the melanocortin system was first recognized as a classical set of circulating hormones released from the pituitary gland with effects on melanocytes and the adrenal cortex, 13 a role for melanocortin peptides and receptors in the brain gradually became apparent from both neuroanatomic and neuropharmacologic approaches. [14] [15] [16] However, understanding the 'real' functions of the melanocortin systemFreal in the context of whole organism physiology and diseaseFdepends greatly on genetic approaches. 4, [17] [18] [19] [20] [21] In the following, we first review briefly the molecular biology of the melanocortin system from the perspective of comparative genomics and evolution, and then discuss how studies of a mouse coat-color mutation led to the discovery of endogenous antagonists for melanocortin receptors: agouti signaling protein (Asip) and agouti-related protein (Agrp). These two proteins originate from a common ancestor early in vertebrate evolution, and share a number of different features; however, we will describe findings from our group and others that have highlighted an important difference in the mechanisms of action for Asip and Agrp, which is reflected in patterns of evolutionary conservation. Finally, we will discuss recent work based on the genetics of pigmentation in domestic dogs that has revealed a new class of ligands for melanocortin receptors, the K locus b-defensins, 22, 23 named after the ability to inhibit microbial growth. 24, 25 Heritable variation in a b-defensin gene causes a simple and strong effect on hair color and reveals a new mechanism for modulating melanocortin signaling and its physiological endpoints.
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The melanocortin system: an evolutionary perspective
Discovery and characterization of the pituitary melanocortin system in the 20th century was prefaced by the work of Thomas Addison nearly 100 years earlier, who described how hyperpigmentation was associated with destruction of the adrenal gland. 13 The underlying pathophysiologyF increased production of pituitary hormones that stimulate both melanocytes and the adrenal cortexFled to work by Aaron Lerner and others, 27, 28 showing that a-melanocyte stimulating hormone (a-MSH) and adrenocorticotrophic hormone (ACTH) were not only closely related in sequence and action, but were also derived by post-translational processing from the same precursor, pro-opiomelanocortin (Pomc), later shown to encode at its C terminus an endorphin ligand for opioid receptors. [29] [30] [31] Initially components of the pituitary-peripheral gland system, the melanocortin pathway is thought to have emerged early in the vertebrate evolution (Figure 1) Figure 1 ). Taken together, these observations suggest that melanocortin receptor duplication and diversification into distinct pathways for controlling of pigmentation and metabolism occurred in a primitive vertebrate more than 500 million years ago, whereas finegrained control over those pathways through paracrine and neuropeptide-based mechanisms was a somewhat more recent invention. Nonetheless, although Agrp and Asip do not appear in the tree of life until after the divergence of jawless fishes from the branch leading to mammals, their structural backbone is much older, as both the characteristic disulfide bonding pattern and the three-dimensional fold are that of the inhibitor cysteine knot (ICK), an ancient protein motif that is widely distributed among invertebrate phyla and used in a variety of invertebrate toxins. [50] [51] [52] An analogous observation holds for b-defensins as melanocortin receptor ligands; the gene family is clearly recognizable in teleost fish (though not in jawless fishes or tunicates), but only became recruited as a melanocortin receptor ligand very recently in mammalian evolution. 22, 23, 26, [53] [54] [55] These observations underscore a central theme of melanocortin signaling: the ability to control a broad array of different physiological processes, which has been driven by a combination of receptor duplication and diversification (the latter with respect to both ligand selectivity and tissue-specific expression), together with the recruitment of previously existing small secreted peptides to serve as new types of melanocortin ligands.
Agouti signaling protein and agouti-related protein: similarities and differences 67, 69 Thus, in retrospect, diversification of melanocortin signaling over hundreds of millions of years led to homologous pathways that control pigmentation and body weight, and the functional relationship between these pathways was revealed by a relatively recent regulatory mutation causing the 'pigmentary' ligand to be expressed in the vicinity of the 'body weight' receptor ( Figure 2a ). An intriguing and important aspect of melanocortin receptor signaling is that both Mc1r and Mc4r exhibit significant basal activity in the absence of a-MSH. 70, 71 Observations based on the phenotype of Pomc mutant mice are particularly telling. On a 129 genetic background, deficiency for Pomc causes obesity and a lightened hair color that is most apparent in the ventrum; 20 on a C57 genetic background, deficiency for Pomc also causes obesity but has no effect on coat color. 19 A key difference between these two genetic backgrounds is in their Agouti genotypes; 129 mice carry light-bellied Agouti (A W ), which causes transient expression of Agouti in the dorsum and consistently high expression in the ventrum, whereas C57 mice carry Nonagouti (a), which is a nearly complete loss of function. These observations suggest that mouse Mc4r is tonically regulated by a-MSH whereas Mc1r is not (Figure 2a) . From a pharmacological perspective, Asip and Agrp are both inverse agonists, 72 capable of eliciting reduced levels of intracellular cAMP through Mc1r and Mc4r, respectively, independent of a-MSH. Sequence similarity between Asip and Agrp is confined to the C-terminal domain of both proteins; nuclear magnetic resonance studies show a nearly identical tertiary structure, 50, 73 in which an antiparallel b-sheet, stabilized by a series of five disulfide bonds, gives rise to several solvent exposed loops (Figure 2b ). As indicated earlier, the same general structure appears in a diverse group of invertebrate toxins; 52 however, the C-terminal domains Asip and Agrp share additional features, including an RFF motif in one of the central loops that serves as a primary point of interaction with melanocortin receptors, and is thought to be responsible for competitive antagonism with a-MSH.
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Asip and Agrp also share the same genomic structure with three protein-coding exons of similar size, indicating that homology between the two genes extends across their entire length. However, the N-terminal sequences of Aisp and Agrp have undergone considerable sequence divergence since duplication. Indeed, a series of studies from our group, 73, 76, 77 and from White and colleagues, 78, 79 reveal that the N-terminal domains of Asip and Agrp have evolved to serve very different functions. The N-terminal domain of Asip contains a glycosylation site and a high density of positively charged residues referred to as the 'basic region.' Initial studies based on transgenic mice suggested that the glycosylation site was important for full activity, but that much of the basic region could be deleted. 80 By contrast, the N-terminal domain of Agrp is charged but amphipathic, and is unstructured based on nuclear magnetic resonance studies. 73 Moreover, the function of the Agrp N-terminal domain is opposite to that of the Asip N-terminal domain, inhibiting rather than facilitating ligand function. This conclusion is on the basis of two lines of evidence. First, the affinity of full-length Agrp for Mc4r is approximately 10-fold less than that of a C-terminal Agrp fragment; 73, 78 second, full-length Agrp is post-translationally cleaved by a proprotein convertase such that the C-terminal domain is the active form in vivo. 78 By contrast, the active form of Asip in tissues is the full-length protein. 82 A summary of the similarities and differences in mechanisms of Asip and Agrp action are summarized in Figure 2a . It is also interesting to consider these results in the context of a molecular evolutionary analysis (Figure 2c) , in which protein alignments of Asip and Agrp from a diverse group of vertebrates were used to estimate regional levels of evolutionary constraint. 73 The C-terminal domains for both proteins are highly constrained, as is a central region of the Asip N-terminal domain. However, the Agrp N-terminal domain is relatively unconstrained, which together with the nuclear magnetic resonance studies suggests that its ability to function as a prodomain has few requirements in terms of protein sequence or tertiary structure.
A new class of melanocortin receptor ligands
An underlying theme of mammalian biology is that basic pathways responsible for phenotypic variation within phyla are broadly conserved among phyla. Some of the groundwork for this idea comes from pioneering studies of Sewall Wright in the early part of the 20th century, in which he recognized that genetic control of coat color with regard to the distribution of red/yellow vs black/brown pigment occurred in a similar fashion among a broad range of different mammals. 83 In particular, variation of Agouti, recognized because of a characteristic banding and/or dorsal-ventral pattern, exhibits an allelic relationship in which 'yellow alleles' are dominant to 'black alleles;' whereas variation of Mc1r (aka Extension) exhibits an opposite relationship with 'black alleles' dominant to 'yellow alleles.' 84 Furthermore, in species where double mutant combinations can be studied, variation of Extension is epistatic to variation of Agouti.
85
An intriguing exception to this theme came from studies by Clarence Cook Little of coat color in domestic dogs. 86 Little was not a stranger to mammalian genetics, having been the founder and the first director of The Jackson Laboratory, and having carried out his graduate work on mouse coat-color genetics. However, Little realized that dominant inheritance of a black coat in domestic dogs was not due to an Extension allele, and proposed instead that dogs carried an unusual Agouti allele, Agouti-self or A Remarkably, all of this work was on the basis of the application of Mendelian principles to segregation analysis and comparative biology, long before the era of molecular genetics. However, nearly 100 years after Wright first described these systems, our laboratory revisited the curious exception represented by the dog A S allele. With the benefit of molecular tools for linkage analysis, the dog Agouti and Mc1r genes, and the entire dog genome sequence, we realized that dominant inheritance of a black coat in domestic dogs was caused by a third gene, not previously appreciated in other mammals, that we named the K locus, in which there were two basic alleles, Black (K B ) and yellow (k y ). 22, 87, 88 Analysis of pedigrees in which Agouti, Mc1r and/or K were present showed that Mc1r was epistatic to both Agouti and K, and that the K B allele was epistatic to the a y allele (Figure 3a) .
We identified the molecular basis of the K locus using an association-based approach that leverages the unique evolutionary history of dogs and dog breeds, 23 and discovered that the mutation from k y to K B was caused by a 3 bp deletion from canine b-defensin 103, CBD103 DG23 . Deletion of Gly23 from CBD103 causes an increased amount of mature CBD103 protein to accumulate in the media of cultured keratinocytes, and transgenic mice that express either CBD103 or CBD103 DG23 controlled by a hybrid CMV/b-actin promoter develop a black coat and a reduced body size; thus, K B represents a gain-of-function or hypermorphic mutation.
Biochemical studies showed that CBD103 DG23 would compete with a-MSH for specific binding to Mc1r. Taken together with the epistasis results, this suggests that a model in which high concentrations of CBD103 DG23 in the skin of K B animals block the ability of Asip to inhibit Mc1r signaling, leading to the increased levels of intracellular cAMP and black pigment synthesis (Figure 3b ).
Other b-defensins as ligands for other melanocortin receptors
The b-defensins (and mammalian defensins in general) are considered to be an important arm of the innate immune Genetics and evolution of melanocortin system CB Kaelin et al system that act as 'endogenous antibiotics.' 24 From the perspective of comparative genomics, the b-defensins are remarkably polymorphic in both sequence and copy number, consistent with a gene family whose evolution is driven by changes in the environment and/or reproductive specialization. 25, 53, 54, 89 However, it has been difficult to establish convincing genotype-phenotype correlations for mammalian defensins in vivo, 90, 91 and the K locus story represents the only example to date in which variation of a b-defensin gene in a natural population has been tied to a simple and strong Mendelian trait. In this context, one of the central questions to emerge from studies of the dog K locus is whether or not other aspects of melanocortin receptor signaling are mediated by b-defensin ligands.
In support of this idea, we observed that at least two human b-defensins, hBD1 and hBD3 (hBD3 is the ortholog of CBD103), bind specifically to the human Mc1r, and that CBD103 DG23 binds specifically to the human Mc4r, albeit with somewhat weaker affinity (Figure 4a ). Furthermore, in transgenic mice, we observed that CBD103 driven by the CMV/b-actin promoter can block both the yellow coat color and partially ameliorate the increased weight gain induced by the A y mutation (Figures 3b and c) . Importantly, the CBD103 transgene causes a reduced body weight by itself (in the absence of A y ), which suggests that the effects of CBD103 on metabolism and growth are complex and is not limited solely to action at Mc4r.
We also note that several groups, particularly those of Tatro,  92,93 Lipton,  94,95 and Luger, 11, 96 have long emphasized the potential for cross talk between the innate immune system and melanocortin signaling. Most of this work has focused on anti-inflammatory and/or antipyretic effects of melanocortin peptides, but it seems possible that defensinmediated modulation of melanocortin receptor signaling could elicit phenotypic endpoints characteristic of the immune system, the endocrine system, or both. In particular, there is strong evidence from several groups that cachexia associated with systemic inflammatory conditions and activation of the innate immune system is mediated, in part, by central melanocortin receptors [97] [98] [99] that could involve an interplay between Pomc-derived peptides and b-defensins.
Conclusions and future directions
Although the primary physiological pathways controlled by the peripheral melanocortin receptors Mc1r and Mc2r were apparent nearly a century before their molecular identification (indeed, the system was named on the basis of these pathways), a critical role for central Mc3 and Mc4 receptors in body weight regulation was much slower to emerge. Initial studies of central melanocortin signaling were based mostly on a stereotyped behavioral responseFthe 'stretchyawn syndrome'Fto pharmacological administration of central melanocortins, [100] [101] [102] [103] with a later appreciation of their antipyretic and anti-inflammatory effects. 11, 93, 104 Ironically, genetic studies have now painted a somewhat different picture for both peripheral and central melanocortin signaling. Although Mc1r itself is a central and critical component that regulates pigmentation, Pomc-derived ligands may play a relatively minor role, as both mice and humans with Pomc mutations have a relatively mild (or no) pigmentary phenotype. Humans and mice with complete deficiency for Mc4r have severe obesity and increased body size, but abnormalities in behavior and/or immune response have not been described. From this perspective, recognizing that a b-defensin mutation gives rise to a Mc1r-dependent pigmentary phenotype is especially interesting, as it provides genetic support for a connection between the melanocortin and immune systems. Nonetheless, hard evidence for a connection between b-defensins and melanocortin receptors is still limited to dog coat color, and it will be important to investigate whether observations on the basis of the K locus are a genetic anomaly or the tip of a genetic iceberg.
